22 January 2018

Is your growth strategy a big deal? Bolt-on deals outperform in latest EY life sciences research

 Whether M&A contributes to shareholder value creation has been an ongoing debate for decades. EY conducted research based on 278 life sciences transactions that closed between 2010 and 2017 to further evaluate this question. We investigated how transaction type (transformative, bolt-on or geographic expansion) affected total shareholder return over several time frames. EY’s findings suggest that bolt-ons were the winner in getting to incremental value faster — impressively so.

Document ID: 2018-5155